![Adrienne Farid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrienne Farid
Keine laufenden Positionen mehr
Vermögen: 612 845 $ am 31.05.2026
Profil
Adrienne Farid worked at Roche Pharmaceuticals, Inc. from 1995 to 2011 as Global Head-Project & Portfolio Management.
From 2014 to 2017, worked at Celgene Corp.
as VP-Project Leadership.
Served as Director at Carisma Therapeutics, Inc. Worked at Century Therapeutics, Inc. from 2021 to 2025 as Chief Development Officer & Head-Early Development from 2024 to 2025.
Education includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Barnard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 250’141 ( 0.14% ) | 612 845 $ | 31.05.2026 |
Ehemalige bekannte Positionen von Adrienne Farid
| Unternehmen | Position | Ende |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Geschäftsführer | 01.10.2024 |
| CELGENE | Corporate Officer/Principal | 01.07.2017 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01.01.2011 |
| CARISMA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Adrienne Farid
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
42
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barnard College
 Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
